What can we learn from monkeys about orthographic processing in humans ? A reply to

What can we learn from monkeys about orthographic processing in humans? A reply to Ziegler et al.

Adopting New International Health Instruments – What Can We Learn From the FCTC?; Comment on “The Legal Strength of International Health Instruments - What It Brings to Global Health Governance?”

This Commentary forms a response to Nikogosian’s and Kickbusch’s forward-looking perspective about the legal strength of international health instruments. Building on their arguments, in this commentary we consider what we can learn from the Framework Convention on Tobacco Control (FCTC) for the adoption of new legal international health instruments.

مدیر موفق کیست؟

Who is a really successful manager? A manager who spends less money, or the one who earns more? A manager who can survive for a longer period of time, or an administrator who expands his organization, and opens up new branches? Which one is the most successful? The article tries to answer these questions and provides, some simple guidlines for the managers in every domain of management who wan...

What Can We Learn from 21 Years of School Poisonings in New Zealand?

Background: Childhood poisoning is a significant international health concern. Very little is known about trends in exposures within schools and preschools. The objectives of this study were to investigate the data recorded by the New Zealand National Poisons Centre (NPC) on these types of exposures over a 21 year period (1989 to 2009) and to determine trends and propose strategies to reduce th...

What Can We Learn About the Processes of Regulation of Tuberculosis Medicines From the Experiences of Health Policy and System Actors in India, Tanzania, and Zambia?

Background The unregulated availability and irrational use of tuberculosis (TB) medicines is a major issue of public health concern globally. Governments of many low- and middle-income countries (LMICs) have committed to regulating the quality and availability of TB medicines, but with variable success. Regulation of TB medicines remains an intractable challenge in many settings, but the reason...